DLHCX
Price
$22.05
Change
-$0.02 (-0.09%)
Updated
Feb 21 closing price
Net Assets
742.22M
JFNIX
Price
$71.71
Change
-$0.51 (-0.71%)
Updated
Feb 21 closing price
Net Assets
5B
Ad is loading...

DLHCX vs JFNIX

Header iconDLHCX vs JFNIX Comparison
Open Charts DLHCX vs JFNIXBanner chart's image
Macquarie Healthcare C
Price$22.05
Change-$0.02 (-0.09%)
VolumeN/A
Net Assets742.22M
Janus Henderson Global Life Sciences I
Price$71.71
Change-$0.51 (-0.71%)
VolumeN/A
Net Assets5B
DLHCX vs JFNIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DLHCX vs. JFNIX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHCX is a Buy and JFNIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 5B vs. DLHCX (742M). JFNIX pays higher dividends than DLHCX: JFNIX (0.15) vs DLHCX (0.00). DLHCX was incepted earlier than JFNIX: DLHCX (15 years) vs JFNIX (16 years). JFNIX is a more actively managed with annual turnover of: 34.00 vs. DLHCX (3.00). DLHCX has a lower initial minimum investment than JFNIX: DLHCX (1000) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -3.63 vs. DLHCX (-9.15). JFNIX return over 5 years is better than : 17.83 vs. DLHCX (-12.95).
DLHCXJFNIXDLHCX / JFNIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years16 years-
Gain YTD5.1005.42594%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets742M5B15%
Annual Yield % from dividends0.000.15-
Returns for 1 year-9.15-3.63252%
Returns for 3 years-7.2416.12-45%
Returns for 5 years-12.9517.83-73%
Returns for 10 years17.0230.0357%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SEMGX19.410.12
+0.62%
DWS Emerging Markets Equity S
MGRDX44.71-0.12
-0.27%
MFS International Growth R6
DBOAX23.89-0.30
-1.24%
BNY Mellon Balanced Opportunity A
PVMIX15.73-0.29
-1.81%
Principal MidCap Value I Inst
GTTUX54.05-1.36
-2.45%
Goldman Sachs Small Cp Val Insghts R6